Avertissement: Ce site agrège des données publiques officielles provenant de la FDA, ClinicalTrials.gov, PubMed et SEC EDGAR à titre de référence générale uniquement. Il ne constitue pas un avis médical, un diagnostic, une recommandation de traitement ni un conseil en investissement.

Essai clinique

Safety of Extending The Routine Flushing Of Implanted Port Devices From 4 Weeks To 12

NCT : NCT05454189 · ACTIVE_NOT_RECRUITING

ID NCTNCT05454189
StatutACTIVE_NOT_RECRUITING
Date de début2022-10-11
Achèvement2026-12-31
SponsorEssentia Health (OTHER)
First posted
Last updated

Résumé succinct

Implanted port devices (IPD) play an essential role in the safe administration of cancer treatments by providing a device to safely administer caustic chemotherapy agents. The current recommended frequency of flushing the IPD per manufacturers guidelines is every 4-6 weeks. The purpose of this study is to find out if extending IPD flushes to every 12 weeks is safe and if it is just as effective as every 4 week flushing.

Source officielle

Voir sur ClinicalTrials.gov →

Données issues de l’API ClinicalTrials.gov. Pour connaître le statut le plus récent, consultez la fiche officielle.

↑